PEPITEM 'replacement therapy' shows potential for early-stage inflammatory arthritis

Scientists investigating the naturally occurring immunopeptide PEPITEM have shown reductions in arthritic joint swelling to a degree comparable to the current standard of care, and reduce the inflammatory changes that cause joint damage.